CPHI Milan 2024, held from October 8–10 at Fiera Milano, marked the 35th anniversary of this landmark pharmaceutical gathering — and it didn’t disappoint. With over 62,000 visitors and 2,400 exhibitors, the event offered a comprehensive snapshot of where the global pharma industry is heading.
Walking the halls, it was impossible to miss the buzz around cutting-edge trends. Sustainability dominated conversations, as companies explored ways to meet strict regulatory requirements while still pushing the envelope on carbon reduction. The focus on eco-conscious innovation felt tangible, with exhibitors highlighting practical approaches to more sustainable manufacturing and supply chains.
Technology was another clear highlight. Discussions around Manufacturing 5.0, AI-driven production, and next-generation biologics revealed a sector increasingly defined by digitalization and precision. The promise of mRNA vaccines and advances in cell and gene therapies reinforced how science continues to accelerate solutions for high-need therapeutic areas, from oncology to diabetes and weight management.
CPHI Milan 2024 painted a vivid picture of a resilient and rapidly evolving pharmaceutical landscape. It was clear that companies are not only innovating at the scientific level but also embracing new ways of working, partnering, and thinking about sustainability. For anyone involved in life sciences, this event confirmed one thing: the industry’s future is collaborative, technology-driven, and ready to tackle the next generation of challenges.
